NCPA Endorses Legislation to Expand Use of Medication Therapy Management Programs

Published Online: Thursday, March 7, 2013
Follow Pharmacy_Times:
PRESS RELEASE

Bipartisan bill will help to reduce costs, improve patient health through better medication adherence

Alexandria, Va. March 7, 2013 - The National Community Pharmacists Association (NCPA) today applauded the introduction of bipartisan legislation (H.R. 1024, the Medication Therapy Management Empowerment Act of 2013) by Reps. Cathy McMorris Rodgers (R-WA) and Ron Kind (D-WI) to expand the pool of patients who qualify for medication therapy management (MTM) programs.

MTM involves pharmacists working with patients to review and monitor their medication plan to maximize its effectiveness and avoid potential health problems, ultimately helping to reduce costs in the long run. With approximately 1.5 million preventable adverse drug effects occurring every year as a result of medication errors, medication therapy programs can greatly improve patient safety.

"NCPA is proud to support common-sense, cost-effective legislation that recognizes the growing contributions of pharmacists to patient care," said NCPA CEO B. Douglas Hoey, RPh, MBA. "Allowing more Medicare beneficiaries to receive one-on-one medication counseling from their trusted pharmacist will ensure that more seniors are taking their medication properly."

H.R. 1024, the Medication Therapy Management Empowerment Act of 2013, will increase the number of Medicare Part D beneficiaries who qualify for one-on-one counseling sessions with a licensed pharmacist to any patient with a chronic medical condition. Currently, only those patients suffering from specific multiple chronic conditions are eligible.

Research indicates that the cost savings from MTM can be significant. One Minnesota study found a 12:1 return-on-investment for MTM. In North Carolina, Kerr Drug reports that MTM programs there helping seniors produced a 13:1 return.

Hoey continued, "With improper use of medication costing an estimated $290 billion a year, medication therapy management programs can reduce serious health risks among patients and save money. NCPA thanks Representatives McMorris Rodgers and Kind for their commitment to improving patient care for America's seniors, and we encourage the House of Representatives to act quickly on this bipartisan legislation."

Related Articles
The National Community Pharmacists Association today praised a Medicare final regulation to discourage Medicare Part D prescription drug plans from paying long-term care pharmacies lower, prorated dispensing fees for "short-cycle" prescriptions.
Seniors would have more convenient access to discounted or "preferred" copays for prescription drugs at their pharmacy of choice under new bipartisan legislation introduced recently and endorsed today by the National Community Pharmacists Association.
The Corrective Action Plan that federal Medicare officials have requested of Aetna is an important first step and the Centers for Medicare & Medicaid Services should go one further by issuing new guidance to all Medicare Part D prescription drug plan sponsors to prevent a 2016 repeat of the Aetna problems experienced in early 2015.
Beneficiaries, CMS, Taxpayers would benefit from uniform approach.
Latest Issues
  • photo
    Pharmacy Times
    photo
    Health-System Edition
    photo
    Directions in Pharmacy
    photo
    OTC Guide
    photo
    Generic Supplements
  • photo
    Pharmacy Careers
    photo
    Specialty Pharmacy Times
    photo
    Generic
$auto_registration$